Market ripe for Bluebird IPO, other first-time public offerings
This article was originally published in Scrip
Executive Summary
The public markets are ripe for biopharma financing as investors continue to pluck fruit from the growing field of drug developers with initial public offerings, including recent IPO filers Iroko Pharmaceuticals, Conatus Pharmaceuticals and Onconova Therapeutics.